Early reports from Wuhan, China, noted that patients with underlying cardiovascular disease had a higher risk of morbidity and mortality if they contracted the COVID-19 virus. More recently, data support that patients with evidence of cardiac disease during their COVID-19 episodes also have higher rates of morbidity and mortality during hospitalization for treatment of COVID-19.

Joining us today to discuss the cardiac involvement in patients with COVID-19 is Patricia A. Pellikka, M.D., vice chair of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota.

Specific topics discussed:
Significance of cardiac involvement in patients with COVID-19
Diagnosis of cardiac dysfunction in patients with COVID-19
Myocarditis and other cardiac injury in patients with COVID-19
Implications of MRI-identified myocarditis
COVID-19 long-haulers and cardiac evaluation
Artificial intelligence in electrocardiogram or echocardiogram

свернуть